Histogen Inc reports results for the quarter ended in December - Earnings Summary

Histogen

11/03/2022 11:27

* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of 7
cents​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 10
cents per share.
    * Revenue fell 99% to $5.00 thousand from a year ago; 
analysts
expected zero. 
    * Histogen Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Histogen Inc shares had fallen by 28.4% this quarter.
    * The company reported a quarterly loss of $3.14 million.
    * Wall Street's median 12-month price target for Histogen
Inc is
$2.70 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 11:27 a.m.  ​All
figures in US dollars unless otherwise stated